Intelligence Β· Patent portfolio
Chongqing Precision Biotech Patents
Full USPTO pharma patent portfolio for Chongqing Precision Biotech β grant dates, expiration, and drug cross-links.
- Patents
- 158
- Expiring β€24m
- 2
Quick answer
Chongqing Precision Biotech has 158 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months β use filters for patent-cliff planning.
-
US 9969975
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9950011
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9950010
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9938344
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
granted -
US 9889161
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9889160
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9814867
Device having titania nanotube membrane for drug delivery
granted -
US 9804298
Ophthalmic lens material
granted -
US 9770412
Implant device for drug delivery
granted -
US 9718866
Colon and pancreas cancer peptidomimetics
granted -
US 9709703
Ophthalmic lens material, ophthalmic lens, and method for making the same
granted -
US 9605077
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 9592290
Monoclonal antibody therapy for pancreas cancer
granted -
US 9526882
Percutaneous administration device and method for producing the same
granted -
US 9511212
Implantable drug delivery device
granted -
US 9433703
Neural graft
granted -
US 9434931
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
granted -
US 9371375
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 9370487
High oil-content emollient aerosol foam compositions
granted -
US 9340777
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
granted -
US 9278066
Topical pharmaceutical foam composition
granted -
US 9169326
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 9089506
Stable, non-irritating topical formulations of hydroquinone
granted -
US 9068014
Colon and pancreas cancer peptidomimetics
granted -
US 9034588
Monoclonal antibody therapy for pancreas cancer
granted -
US 9018236
Cyclodextrin-based microemulsions, and dermatological uses thereof
granted -
US 8975295
Modulation of zinc levels to improve tissue properties
granted -
US 8840978
Identification device having antimicrobial properties
granted -
US 8828725
Culture medium
granted -
US 8808866
Coated elastomeric article and method for making a coated elastomeric article
granted -
US 8802090
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 8784780
High oil-content emollient aerosol foam compositions
granted -
US 8740615
Implant, implant body, and abutment body
granted -
US 8695119
Coated elastomeric article and method for making a coated elastomeric article
granted -
US 8652443
Foamable microemulsion compositions for topical administration
granted -
US 8623330
Emollient foams for treatment of seborrheic dermatitis
granted -
US 8592380
Aerosol foams comprising clindamycin phosphate
granted -
US 8546364
Stabilized steroid composition and method for its preparation
granted -
US 8535667
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 8524456
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 8470326
Monoclonal antibody therapy for pancreas cancer
granted -
US 8445251
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
granted -
US 8445044
Food thickening agent, method for producing food thickening agent
granted -
US 8389502
Stabilized steroid composition and method for its preparation
granted -
US 8365314
Coated elastomeric article and method for making a coated elastomeric article
granted -
US 8221138
Audio jack connector with improved soldering tail
granted -
US 8183009
Assaying cellular markers for the evaluation of tumors
granted -
US 8173120
Method of preventing reduced feed intake in animals and treatment of disease conditions
granted
Frequently asked questions
How many patents does Chongqing Precision Biotech have?
158 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Chongqing Precision Biotech patents expire?
2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory